Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 378

1.

Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases.

Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M, Ikeuchi M, Tani T, Fujieda M, Wakiguchi H, Imai S.

J Infect Chemother. 2005 Oct;11(5):211-9. Review.

PMID:
16258815
2.

Phage therapy: facts and fiction.

Skurnik M, Strauch E.

Int J Med Microbiol. 2006 Feb;296(1):5-14. Epub 2005 Nov 15. Review.

PMID:
16423684
3.

Preventing biofilms of clinically relevant organisms using bacteriophage.

Donlan RM.

Trends Microbiol. 2009 Feb;17(2):66-72. doi: 10.1016/j.tim.2008.11.002. Epub 2009 Jan 21. Review.

PMID:
19162482
4.

Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates.

López-Brea M, Alarcón T, Domingo D, Díaz-Regañón J.

J Antimicrob Chemother. 2008 Jan;61(1):139-42. Epub 2007 Oct 26.

PMID:
17965421
5.

Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria.

Lai MJ, Lin NT, Hu A, Soo PC, Chen LK, Chen LH, Chang KC.

Appl Microbiol Biotechnol. 2011 Apr;90(2):529-39. doi: 10.1007/s00253-011-3104-y. Epub 2011 Jan 25.

PMID:
21264466
6.

Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).

Nørskov-Lauritsen N, Marchandin H, Dowzicky MJ.

Int J Antimicrob Agents. 2009 Aug;34(2):121-30. doi: 10.1016/j.ijantimicag.2009.02.003. Epub 2009 Apr 1.

PMID:
19342205
7.

Infectious crystalline keratopathy caused by gram-negative bacteria.

Khater TT, Jones DB, Wilhelmus KR.

Am J Ophthalmol. 1997 Jul;124(1):19-23.

PMID:
9222227
8.

The Effect of Bacteriophage Preparations on Intracellular Killing of Bacteria by Phagocytes.

Jończyk-Matysiak E, Łusiak-Szelachowska M, Kłak M, Bubak B, Międzybrodzki R, Weber-Dąbrowska B, Żaczek M, Fortuna W, Rogóż P, Letkiewicz S, Szufnarowski K, Górski A.

J Immunol Res. 2015;2015:482863. doi: 10.1155/2015/482863. Epub 2015 Dec 9.

9.

Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST).

Bouchillon SK, Iredell JR, Barkham T, Lee K, Dowzicky MJ.

Int J Antimicrob Agents. 2009 Feb;33(2):130-6. doi: 10.1016/j.ijantimicag.2008.07.031. Epub 2008 Nov 7.

PMID:
18995992
10.

Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.

Burrowes B, Harper DR, Anderson J, McConville M, Enright MC.

Expert Rev Anti Infect Ther. 2011 Sep;9(9):775-85. doi: 10.1586/eri.11.90. Review.

PMID:
21905786
11.
13.
14.

Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison.

Duggirala A, Joseph J, Sharma S, Nutheti R, Garg P, Das T.

Indian J Ophthalmol. 2007 Jan-Feb;55(1):15-9.

15.

Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.

Roveta S, Marchese A, Debbia EA.

Chemotherapy. 2008;54(1):43-9. Epub 2007 Dec 10.

PMID:
18073470
16.

[Distribution of bacteria isolated from urine cultures in Malatya University Hospital laboratory (letter)].

Yetkin G, Kuzucu C, Güçlüer N.

Mikrobiyol Bul. 2006 Oct;40(4):445-6. Turkish.

PMID:
17205704
17.

[Antimicrobial activity of soft and purified propolis extracts].

Pavilonis A, Baranauskas A, Puidokaite L, Mazeliene Z, Savickas A, Radziūnas R.

Medicina (Kaunas). 2008;44(12):977-83. Lithuanian.

18.

Bacteriophages and bacteriophage-derived endolysins as potential therapeutics to combat Gram-positive spore forming bacteria.

Nakonieczna A, Cooper CJ, Gryko R.

J Appl Microbiol. 2015 Sep;119(3):620-31. doi: 10.1111/jam.12881. Epub 2015 Aug 2. Review.

PMID:
26109320
19.

[New perspectives of the phage therapy].

Eyer L, Pantůcek R, Růzicková V, Doskar J.

Klin Mikrobiol Infekc Lek. 2007 Dec;13(6):231-5. Review. Czech.

PMID:
18320502
20.

Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.

McGowan JE Jr.

Am J Med. 2006 Jun;119(6 Suppl 1):S29-36; discussion S62-70. Review.

PMID:
16735148

Supplemental Content

Support Center